BCR Share Price

Open 207.94 Change Price %
High 212.43 1 Day 3.10 1.50
Low 207.37 1 Week -2.65 -1.25
Close 209.96 1 Month -7.17 -3.30
Volume 543395 1 Year 26.70 14.57
52 Week High 239.43
52 Week Low 172.21
BCR Important Levels
Resistance 2 214.65
Resistance 1 212.72
Pivot 209.92
Support 1 207.20
Support 2 205.27
NYSE USA Most Active Stocks
BAC 21.23 -1.26%
BAC 21.23 -1.26%
BAC 21.23 -1.26%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
WSH 47.18 -2.86%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
CAS 0.51 24.39%
VNR 0.91 19.74%
VNR 0.91 19.74%
P 13.33 16.11%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
OIBR 0.17 -43.33%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

C.R. Bard, Inc. (NYSE: BCR)

BCR Technical Analysis 3
As on 2nd Dec 2016 BCR Share Price closed @ 209.96 and we RECOMMEND Sell for LONG-TERM with Stoploss of 211.63 & Sell for SHORT-TERM with Stoploss of 218.78 we also expect STOCK to react on Following IMPORTANT LEVELS.
BCR Target for December
1st Target up-side 222.15
2nd Target up-side 230.29
3rd Target up-side 238.42
1st Target down-side 198.95
2nd Target down-side 190.81
3rd Target down-side 182.68
BCR Other Details
Segment EQ
Market Capital 8042701824.00
Sector Healthcare
Industry Medical Instruments & Supplies
Offical website http://www.crbard.com
BCR Address
BCR
730 Central Avenue
Murray Hill, NJ 07974
United States
Phone: 908-277-8000
Fax: 908-277-8412
Interactive Technical Analysis Chart C.R. Bard, Inc. ( BCR NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on C.R. Bard, Inc.
BCR Business Profile
C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular products, including percutaneous transluminal angioplasty catheters, chronic total occlusion catheters, guidewires, fabrics, meshes, introducers, and accessories; valvuloplasty balloons; peripheral vascular stents, covered stents, and vascular grafts; vena cava filters; biopsy devices; and temporary pacing electrode catheters for the treatment of peripheral vascular disease and heart arrhythmias. The company’s urology products include Foley catheters to reduce the rate of urinary tract infections; surgical slings to treat stress urinary incontinence; fecal incontinence products; devices for the treatment of pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal; catheter stabilization devices; and products for therapeutic hypothermia. It also provides specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers and other diseases and disorders. In addition, the company offers surgical specialty products, such as implanted grafts and fixation devices for hernia and soft tissue repair products; surgical sealants for intraoperative sealing of air leaks in thoracic surgery; and other products that include irrigation, wound drainage, and original equipment manufacturers’ products. It sells its products directly to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities, as well as through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.